Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Santhi Swaroop Vege

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-5742-2963; OpenAlex author ID A5003145416; NIH RePORTER profile ID 9797596. Sources: ClinicalTrials.gov.

Their work

Papers
14
Trials
1 (principal investigator on 1)
Grants
1
Labs led
1
Collaborators
67
Papers, trials and grants by year

2015: 1 paper, 1 trial · 2016: none · 2017: 1 paper · 2018: 2 papers · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 4 papers, 1 grant

Papers 14

  1. Towards early detection of pancreatic cancer: The current status of cohort studies by the Diabetes-Pancreatic Ductal AdenoCarcinoma Working Group. Co-author DOI 10.1016/j.pan.2026.04.020↗
  2. Risk of Pancreatic Cancer in Glycemically Defined New-Onset Diabetes: A Prospective Cohort Study. Co-author DOI 10.1053/j.gastro.2025.06.025↗
  3. Adult Chronic Pancreatitis Working Group: Goals, Accomplishments and the Path Ahead. A Report From the Consortium for the Study of Chronic Pancreatitis, Diabet… Co-author DOI 10.1097/mpa.0000000000002657↗
  4. Safety and Diagnostic Performance of Pancreatic Duct Brushings for Detecting Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000002714↗
  5. Long-Term Outcomes and Risk of Pancreatic Cancer in Intraductal Papillary Mucinous Neoplasms. Co-author DOI 10.1001/jamanetworkopen.2023.37799↗
  6. Pancreatic Cancer is More Frequently Early Stage at Diagnosis in Surgically Resected Intraductal Papillary Mucinous Neoplasms With Preoperative Surveillance. Co-author DOI 10.1016/j.gastha.2022.07.004↗
  7. Perception versus reality: A National Cohort Analysis of the surgery-first approach for resectable pancreatic cancer. Co-author DOI 10.1002/cam4.4144↗
  8. Determining age and sex-specific distribution of pancreatic whole-gland CT attenuation using artificial intelligence aided image segmentation: Associations wit… Co-author DOI 10.1016/j.pan.2021.08.004↗
  9. Methylated DNA in Pancreatic Juice Distinguishes Patients With Pancreatic Cancer From Controls. Co-author DOI 10.1016/j.cgh.2019.07.017↗
  10. High-Grade Dysplasia in Resected Main-Duct Intraductal Papillary Mucinous Neoplasm (MD-IPMN) is Associated with an Increased Risk of Subsequent Pancreatic Canc… Co-author DOI 10.1038/s41395-018-0403-2↗
  11. Risk of Pancreatic Cancer in Patients With Pancreatic Cysts and Family History of Pancreatic Cancer. Co-author DOI 10.1016/j.cgh.2018.01.049↗
  12. Advances in Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasms, and Pancreatitis. Co-author DOI 10.1053/j.gastro.2018.05.019↗
  13. Endoscopic Ultrasound Fine-Needle Aspiration Diagnosis of Synchronous Primary Pancreatic Adenocarcinoma and Effects on Staging and Resectability. Co-author DOI 10.1016/j.cgh.2016.08.009↗
  14. Impact of celiac neurolysis on survival in patients with pancreatic cancer. Co-author DOI 10.1016/j.gie.2014.12.036↗

Trials 1

  1. Pentoxifylline Treatment in Acute Pancreatitis (AP) Principal investigator NCT02487225↗

Grants 1

  1. The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer U01DK108288↗

Closest collaborators

The 25 strongest of 67 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Suresh T. Chari · 10 shared papers, 1 shared grant, 2015–2026 · strength 2.03
  2. Mark D. Topazian · 6 shared papers, 1 shared grant, 2015–2026 · strength 1.41
  3. Gloria M. Petersen · 1 shared paper, 1 shared grant, 2020–2026 · strength 0.94
  4. Shounak Majumder · 6 shared papers, 2019–2026 · strength 0.78
  5. Randall K. Pearson · 7 shared papers, 2015–2026 · strength 0.72
  6. Phil A. Hart · 3 shared papers, 2026 · strength 0.69
  7. Stephen Jacob Pandol · 3 shared papers, 2018–2026 · strength 0.64
  8. Michael J. Levy · 7 shared papers, 2015–2022 · strength 0.55
  9. Ferga C. Gleeson · 6 shared papers, 2015–2022 · strength 0.48
  10. Christopher E Forsmark · 2 shared papers, 2026 · strength 0.47
  11. Evan L Fogel · 2 shared papers, 2026 · strength 0.47
  12. Walter Gwang-Up Park · 2 shared papers, 2026 · strength 0.47
  13. Vinay Chandrasekhara · 3 shared papers, 2021–2026 · strength 0.47
  14. Anirban Maitra · 2 shared papers, 2026 · strength 0.46
  15. William E Fisher · 2 shared papers, 2026 · strength 0.46
  16. Jo Ann Rinaudo · 2 shared papers, 2026 · strength 0.46
  17. Naoki Takahashi · 4 shared papers, 2018–2023 · strength 0.40
  18. Michael L. Kendrick · 4 shared papers, 2017–2022 · strength 0.38
  19. Mark Joseph Truty · 3 shared papers, 2017–2022 · strength 0.30
  20. Jaime de la Fuente · 2 shared papers, 2022–2023 · strength 0.27
  21. Rondell Patrell Graham · 2 shared papers, 2022–2023 · strength 0.27
  22. Arjun Chatterjee · 2 shared papers, 2022–2023 · strength 0.27
  23. Motaz H. Ashkar · 1 shared paper, 2026 · strength 0.24
  24. Shuji Mitsuhashi · 1 shared paper, 2026 · strength 0.24
  25. Eric J. Vargas · 1 shared paper, 2026 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.